According to this paradigm, weight loss increases KATP current density, which increases glucose-stimulated insulin secretion in people with T2D who have “crossed over” but decreases glucose-stimulated insulin secretion in people with obesity who have not “crossed over,” as observed in our participants. The gene discussed is INS; the disease is type 2 diabetes mellitus.